Rhinosporidiosis
Rhinosporidiosis is a slowly progressive, chronic granulomatous infection that produces strawberry-like vascular polyps which bleed easily. It most often affects the lining of the nose, the pharynx and the conjunctiva of the eye.
Historically it was grouped with the deep fungal infections because its sporangia look like those of fungi, but modern molecular studies (18S rRNA sequencing) have shown that the causative organism, Rhinosporidium seeberi, actually belongs to the Mesomycetozoea (the DRIP clade), aquatic single-celled organisms on the boundary between animals and fungi. At Haute-Derma, our management of rhinosporidiosis focuses on early recognition of its characteristic sporangial granulomas and on excising the polyp at its base with thorough electrocoagulation to reduce the high risk of recurrence.
Pathogenesis and Life Cycle
The Organism Rhinosporidium seeberi and Its Source
- Rhinosporidium seeberi is an aquatic microorganism that has never been grown in vitro.
- Source: stagnant fresh water, ponds, lakes, rivers and streams in tropical and subtropical regions.
- Route of entry: through scratches or tiny breaks in the mucosa while bathing, swimming or washing the face in contaminated pond or lake water.
Developmental Cycle in Tissue
In human tissue, R. seeberi passes through stages that differ markedly in size:
- Free spore (trophozoite / endospore): small (6–8 µm), single cells with a distinct nucleus.
- Mature sporangium: the cell enlarges enormously into a giant sphere 100–350 µm across, visible to the naked eye as tiny white dots on the polyp surface.
- Spore release: each sporangium holds thousands of endospores. When it ruptures through its pore, the endospores spill into the surrounding stroma and start a new cycle of infection, provoking a highly vascular granulomatous reaction.
Clinical Forms
Nasal and Nasopharyngeal Form (70%–80% of cases):
- A soft, pink-red or pale gray polypoid growth, stalked or broad-based, with a bumpy surface dotted with countless tiny white or yellow spots (superficial sporangia just beneath the mucosa).
- Symptoms: one-sided nasal blockage, blood-stained nasal discharge, a sensation of something in the nose and recurrent nosebleeds.
Ocular Form (15%–20% of cases):
- Polyps arise on the palpebral or bulbar conjunctiva or in the lacrimal sac.
- Symptoms: a gritty foreign-body sensation, constant tearing and a red, papilloma-like lump that bleeds easily with blinking.
Cutaneous and Other Extranasal Forms (Rare): secondary skin lesions from autoinoculation from nasal or ocular sores, appearing as warty nodules or verrucous plaques attached to the surrounding skin.
Clinical and Histologic Differential Diagnosis
| Rhinosporidiosis | Ordinary Nasal Polyp | Squamous Cell Carcinoma of the Nasal Mucosa (SCC) |
|---|---|---|
| Red, strawberry-like papillary mass with tiny white dots | Translucent gray polyp with a smooth surface | Necrotic, ulcerated, invasive growth that bleeds easily |
| Bleeds very easily with light contact | Rarely bleeds spontaneously | Bleeds easily from necrotic areas |
| Giant sporangia (100–350 µm) packed with endospores | No sporangia; many eosinophils | Atypical epithelial cells with abnormal mitoses |
| Hyperplastic mucosa with numerous thick-walled sporangia in the stroma | Edematous connective tissue stroma with eosinophil infiltration | Malignant keratinocytes breaching the basement membrane |
| Cannot be cultured | No microorganism | No microorganism |
Standard Diagnostic Workup at Haute-Derma
Surface Examination and Cytology:
- Touch smear / aspiration: a cotton swab is gently wiped across the surface of the strawberry-like polyp, or a small tissue sample is crushed between two glass slides.
- KOH / Giemsa wet mount: immediately reveals giant spherical sporangia (up to 300 µm across) containing thousands of round or disc-shaped endospores (6–9 µm across).
Mandatory Biopsy for Histopathology:
- Epithelium/mucosa: edematous, irregularly hyperplastic, or thinned by pressure from the mass.
- Stroma: a chronic inflammatory granulomatous reaction with marked vascular proliferation (which explains the tendency to bleed).
- Characteristic organisms: numerous sporangia at different stages of development:
- Immature, thin-walled sporangia with a central nucleus.
- Mature sporangia with very thick walls, packed with endospores.
- Ruptured sporangia: collapsed walls surrounded by multinucleated giant cells and neutrophils.
- Special stains: the spores and sporangial walls stain strongly with PAS (periodic acid–Schiff) and GMS (Grocott's methenamine silver).
Treatment at Haute-Derma
Surgical Excision With Electrocautery of the Polyp Base
Because Rhinosporidium seeberi cannot be cultured and responds very poorly to standard antifungal drugs, complete surgical removal is the mainstay of treatment:
- Technique: the papillary polyp is excised in one piece.
- Electrocautery of the base: the surgical base (the polyp's attachment) must be thoroughly cauterized to destroy sporangia lying deep in the submucosa. Removing the mass without cauterizing its base is the main reason recurrence rates can exceed 50%.
Adjuvant Medical Therapy to Prevent Recurrence
- Dapsone:
- Mechanism: dapsone inhibits maturation of the sporangia and blocks folic acid synthesis in R. seeberi.
- Dose: 100 mg/day for 3–6 months after surgery.
- Indications: especially useful for extensive disease, when surgery cannot remove the entire base, or in patients with repeated recurrences.